We have located links that may give you full text access.
Effectiveness of an intravenous protection device in pediatric patients on catheter dwell time and phlebitis score.
Asian Nursing Research 2019 September 26
PURPOSE: The study aimed to examine the efficacy of the I.V. House® UltraDressing® for protecting peripheral intravenous catheters (PIVCs) in pediatric patients.
METHODS: This randomized controlled trial comprised 60 pediatric patients (aged 2-24 months): 30 in the experimental group and 30 in the control group. The PIVC dwell time, and phlebitis scores were also reported for both groups. The degree of phlebitis was determined using the Visual Infusion Phlebitis Scale (VIPS) and was recorded every 8 hours from the start of antibiotic therapy until catheter removal.
RESULTS: The mean catheter dwell time in the experimental group (2.10±1.55 days) was significantly longer than that of the control group (1.27±0.45 days) (p<0.010). However, there were no significant differences between the scores and signs of phlebitis in both groups (p>0.050).
CONCLUSION: The I.V. House® UltraDressing® is a useful device that can be used to increase catheter dwell time and protect and stabilize PIVCs in pediatric patients.
METHODS: This randomized controlled trial comprised 60 pediatric patients (aged 2-24 months): 30 in the experimental group and 30 in the control group. The PIVC dwell time, and phlebitis scores were also reported for both groups. The degree of phlebitis was determined using the Visual Infusion Phlebitis Scale (VIPS) and was recorded every 8 hours from the start of antibiotic therapy until catheter removal.
RESULTS: The mean catheter dwell time in the experimental group (2.10±1.55 days) was significantly longer than that of the control group (1.27±0.45 days) (p<0.010). However, there were no significant differences between the scores and signs of phlebitis in both groups (p>0.050).
CONCLUSION: The I.V. House® UltraDressing® is a useful device that can be used to increase catheter dwell time and protect and stabilize PIVCs in pediatric patients.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app